In previous studies in mice (39, 40), inhibition of miR-375 by interleukin-10 administration or anti-miR-375 therapy enhanced cardiac recovery and reduced inflammatory response after myocardial infarction by activation of the PDK-1-AKT pathway. Here, PDK1 is linked to myocardial infarction.